222 related articles for article (PubMed ID: 7908057)
1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
[TBL] [Abstract][Full Text] [Related]
2. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569
[TBL] [Abstract][Full Text] [Related]
3. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
4. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
Takeda H; Igawa Y; Komatsu Y; Yamazaki Y; Akahane M; Nishizawa O; Ajisawa Y
Eur J Pharmacol; 2000 Sep; 403(1-2):147-55. PubMed ID: 10969156
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
Horinouchi T; Koike K
Pharmacology; 1999 Dec; 59(6):290-7. PubMed ID: 10575323
[TBL] [Abstract][Full Text] [Related]
8. Effects of the beta 3-adrenoceptor agonist BRL 37344 on lipomobilization and plasma glucose levels in conscious fasted rabbits.
Reverte M; Rivas-Cabañero L
Can J Physiol Pharmacol; 1996 Mar; 74(3):251-6. PubMed ID: 8773403
[TBL] [Abstract][Full Text] [Related]
9. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway.
Tamaoki J; Tagaya E; Isono K; Nagai A
Biochem Biophys Res Commun; 1998 Jul; 248(3):722-7. PubMed ID: 9703994
[TBL] [Abstract][Full Text] [Related]
10. A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats.
Atef N; Lafontan M; Doublé A; Hélary C; Ktorza A; Pénicaud L
Eur J Pharmacol; 1996 Mar; 298(3):287-92. PubMed ID: 8846828
[TBL] [Abstract][Full Text] [Related]
11. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
13. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220
[TBL] [Abstract][Full Text] [Related]
14. Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery.
Leblais V; Pourageaud F; Ivorra MD; Guibert C; Marthan R; Muller B
J Pharmacol Exp Ther; 2004 Apr; 309(1):137-45. PubMed ID: 14718590
[TBL] [Abstract][Full Text] [Related]
15. Effects of beta-adrenergic stimulation on the acutely obstructed ureter in dogs.
Murakami M; Tomiyama Y; Hayakawa K; Akahane M; Ajisawa Y; Park YC; Ohnishi N; Sugiyama T; Kurita T
J Pharmacol Exp Ther; 2000 Jan; 292(1):67-75. PubMed ID: 10604932
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Leblais V; Pourageaud F; Ivorra MD; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):535-9. PubMed ID: 16012871
[TBL] [Abstract][Full Text] [Related]
17. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
Shen YT; Cervoni P; Claus T; Vatner SF
J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
[TBL] [Abstract][Full Text] [Related]
18. Effects of epinephrine, isoproterenol and IPS-339 on sympathetic transmission to the dog heart: evidence against the facilitatory role of presynaptic beta adrenoceptors.
Yorikane R; Kanda A; Kimura T; Satoh S
J Pharmacol Exp Ther; 1986 Jul; 238(1):334-40. PubMed ID: 3014122
[TBL] [Abstract][Full Text] [Related]
19. Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
Horinouchi T; Koike K
Eur J Pharmacol; 2000 Sep; 403(1-2):133-8. PubMed ID: 10969154
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
